Content
Pharma M&A Bubble Alive And Well After Pfizer Confirms AstraZeneca Bid; AZN Demands More
Article By:
Tyler Durden
Read
Monday, April 28, 2014 9:17 AM EDT
While the news that Pfizer has been sniffing around AstraZeneca has been around for a while, it is the confirmation this morning from Pfizer that it is considering a cash and stock offer for AZN that has been the catalyst to push futures off their early trading levels
Biggest Credit Bubble In History Runs Out Of Time
Article By:
Lee Adler
Read
Friday, April 25, 2014 5:41 AM EDT
It has been a feeding frenzy for junk debt. Yield-desperate investors, driven to near insanity by the Fed’s strenuous interest-rate repression, are holding their noses and closing their eyes, and they’re bending down deep into the barrel and scrape up even the crappiest and riskiest paper just to get that little extra yield.
In this article: BMC
How Bill Ackman Scrambled To Acquire Over $3 Billion In Allergan Calls Knowing Valeant Would Submit A Bid
Article By:
Tyler Durden
Read
Tuesday, April 22, 2014 1:24 PM EDT
In yet another page of the activist investor's sleaze book, last night Bill Ackman showed that when it comes to unethical way to generate "alpha" he truly may have no equal, when we learned that together with serial-acquirer and employee terminator Valeant, Ackman's Pershing Square would join in on a debt-funded acquisition of botox maker Allergan.
Sector Detector: Rejuvenated Market Seeks Follow-Through, But Earnings Loom Large
Article By:
Sabrient Systems
Read
Tuesday, April 22, 2014 10:12 AM EDT
Weakness the prior week was due in part to traders exiting positions for vacation during the holiday-shortened week, protecting big capital gains, cashing out to pay taxes on capital gains, and “delta hedging” on put options.
In this article: AGN, BAC, GE, IBM, LLL, MCD, MS, T, BIIAF, RVBD, SLXP, AAPL, AMZN, GOOG, INTC, MSFT, NFLX, QCOM, SBUX, SNDK, XLNX, YHOO, IDU, IYC, IYE, IYF, IYH, IYJ, IYK, IYM, IYW, IYZ, SPY, META, VIX
Goodbye Biotech "Growth Bubble"; Hello Pharma "M&A Bubble" - Novartis Enters Fray With $25 Billion In Transactions
Article By:
Tyler Durden
Read
Tuesday, April 22, 2014 9:58 AM EDT
While the rest of the market has been largely quiet as earnings week unfolds, it have been the pharma companies that has stolen the spotlight in the past few days.
Aspen Board Right To Turn Down Endurance’s Offer
Article By:
David Trainer
Read
Wednesday, April 16, 2014 5:15 AM EDT
Endurance Specialty Holdings (ENH) made a $3.2 billion takeover bid for Aspen Insurance Holdings (AHL) on Monday. After months of fruitless negotiations, ENH attempted to bypass AHL’s management and reach out to shareholders directly. We think ENH’s offer undervalues the stock.
Twitter Buys Long-Time Partner Gnip, A Social Data Company
Article By:
Shelly Palmer
Read
Tuesday, April 15, 2014 12:52 PM EDT
After a longstanding relationship with the company, Twitter has decided to acquire Gnip, “a leading provider of social data.”
Scandals At Drug Companies, Russian Plays, Chinese Grandma Stocks
Article By:
Vivian Lewis
Read
Tuesday, April 8, 2014 6:54 AM EDT
The first will doubtless feature the global economy's dependency on exceptionally low interest rates. Britain and the US have only been able to revert to their trend rate of growth through looser and looser monetary policy.
In this article: RUS.L, GSK, SBS, 9984.TSE, MNGGF, MXCHF, PDYPF, TCEHY, QCOR, TEVA, YNDX, CGEN, MNK, FBASF, CAMK.L
6 Reasons US M&A Activity Will See Strong Growth This Year
Article By:
Sober Look
Read
Wednesday, April 2, 2014 5:58 AM EDT
US M&A activity is picking up steam. Deal volume in the first quarter of this year was the highest since 2007 (in dollar terms). The total of $278bn of transactions includes high profile deals such as Time Warner, Forest Laboratories, and WhatsApp.
Facebook Should Have Purchased GT Nexus And Move Supply-Chains To The Cloud
Article By:
Marc Courtenay
Read
Wednesday, March 26, 2014 2:08 PM EDT
What was Facebook thinking when it paid $2 billion for virtual reality company Oculus VR, when it could have offered to buy a company like GT Nexus and built some real value into its repertoire.
In this article: META
Will The Backlash Against Facebook Be The Doom Of Its Acquisition Spree?
Article By:
Tyler Durden
Read
Wednesday, March 26, 2014 12:33 PM EDT
Spending your inordinately over-valued 'currency' on an ever-reaching (and increasingly over-valued) portfolio of dreams may have been the stuff of expanding multiples and social media stock-lovers; but for the creator of Minecraft (among the world's most popular games), Facebook's move to buy Oculus was the last straw.
In this article: META
50% Profit Growth And Historical Realities
Article By:
Lance Roberts
Read
Tuesday, March 4, 2014 1:59 PM EDT
As the markets push once again into record territory the question of valuations becomes ever more important. While valuations are a poor timing tool in the short term for investors, in the long run valuation levels have everything to do with future returns.
I Am Out Of Tune With These Times
Article By:
Bronte Capital
Read
Friday, February 21, 2014 12:00 AM EDT
At core I am an old-fashioned value investor. Maybe a growth-orientated one - but the valuation has to make sense on fairly modest assumptions before I get excited.
2013 Deal Valuations Reach All Time Highs; What’s In Store For 2014?
Article By:
John Slater
Read
Friday, February 14, 2014 5:53 PM EDT
Last March we predicted that middle market business sale values in 2013 could reach all-time high levels. Recent data from Pitchbook confirms that was in fact the case.
Emerging Market Insanity: Bought PVD For Peanuts
Article By:
Dr. Paul Price
Read
Monday, January 27, 2014 8:35 AM EDT
Last week's panic in EM ETFs and shares made for great prices on high-quality stocks.
Here's how my Friday trading went with a blue-chip holding.
In this article: PVD